Disease/Condition
1,961 Clinical Trials
10+ Countries
COVID-19 Clinical Trials Database - Free Access to 1,961 Studies
Access comprehensive clinical trial information for COVID-19 through Pure Global AI's free database. This collection includes 1,961 clinical trials across multiple phases including N/A, Phase 2, Phase 3. Currently, 587 trials are actively recruiting participants.
Research for COVID-19 is being conducted in United States of America, China, Japan and 7+ other countries. Leading sponsors include National Institute of Allergy and Infectious Diseases (NIAID) and Assistance Publique - Hôpitaux de Paris. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Free Database
Powered by Pure Global AI
840K+ Global Trials
Updated Daily
By Phase
N/A
939Phase 2
294Phase 3
247Phase 1
146Phase 2/3
107By Status
Completed
614Recruiting
587Not yet recruit...
426Terminated
73Withdrawn
54Top Countries
United States of America305
China184
Japan123
Iran115
France81
Top Sponsors
National Institute...23
Assistance Publiqu...22
Sinovac Research a...19
Pfizer18
Shahid Beheshti Un...17
Recent Trials
Latest clinical trials for COVID-19
2020-002482-34
Octagam 10% therapy in COVID-19 patients with severe disease progression
Octapharma USA
SLCTR_2020_026
Not Applicable
Suspended
Effects on the clinical evolution of patients with respiratory infection secondary to the Sars-CoV-2 virus, when they are maintaining communication with family/friends through mobile devices compared to patients not having an option of communication
Center for Research in Policie...American Samoa
PHRR220620-004783
Phase 3
Ongoing
A Phase 3, Randomized, Double-Blind, Active-Controlled, Confirmatory Study to Compare the Immunogenicity, Efficacy, and Safety of KD-414 Vaccine and Vaxzevria Vaccine in Adults Aged 18 years and Older
Meiji Seika Pharma Co., Ltd.Japan Philippines
PHRR220912-004985
Phase 2/3
Ongoing
A Phase II/III, Randomized, Double-blinded Study to Evaluate the Efficacy, Safety and Immunogenicity of a Booster Dose of PIKA-Adjuvanted Recombinant SARS-CoV-2 Spike (S) Protein Subunit Vaccine in Adults ≥ 18 Years Old Who Received 2 or more doses of Inactivated Covid-19 Vaccine
Yisheng Biopharma (Singapore) ...Philippines United Arab Emirates
PHRR220304-004370
Phase 1/2
Terminated
A Safety, Tolerability, and Efficacy Study of IBI314 in Ambulatory Patients with COVID-19
Innovent Biologics (Suzhou) Co...Brazil Philippines United States
PHRR220718-004884
Not Applicable
Completed
Virgin coconut oil (VCO) supplementation modestly relieves symptoms and inflammation among mild to moderate COVID-19 patients: A single-blind randomized trial
Food and Nutrition Research In...Philippines
PHRR220725-004901
Not Applicable
Completed
Virgin coconut oil is effective in lowering C-reactive protein levels among suspect and probable cases of COVID-19
Food and Nutrition Research In...Philippines
SLCTR_2021_002
Phase 2
Completed
Efficacy and safety of Link Natural Sudarshana tablet (an Ayurvedic medicine) against COVID-19 infection – A single center, randomized double-blind, placebo-controlled clinical trial
Link Natural Products (Pvt) Lt...Sri Lanka
SLCTR_2021_034
Phase 3
Recruiting
Multicenter, randomized, double-blinded, placebo-controlled, phase 3 clinical efficacy study evaluating nitric oxide nasal spray (NONS) as a prevention treatment for individuals at risk of exposure to COVID-19 infection
SaNOtize Research and Developm...Sri Lanka
SLCTR_2021_026
Phase 3
VAT00008: A parallel-group, Phase III, multi-stage, modified double-blind, Placebo-Controlled, multi-armed study to assess the efficacy, safety, and immunogenicity of two SARS-CoV-2 Adjuvanted Recombinant Protein Vaccines (monovalent- CoV2 preS dTM-AS03 (D614) and bivalent CoV2 preS dTM-AS03 (D614 + B.1.351)) for prevention against COVID-19 in adults 18 years of age and older.
Sanofi Pasteur Inc.Japan, Mexico, Pakistan, Sri Lanka, United States of America
SLCTR_2021_020
Phase 2
Recruiting
A randomized control trial to assess the efficacy and safety of ivermectin in the treatment of mild to moderate COVID 19 patients
Dr Ananda WijewickramaSri Lanka
NCT06402279
Completed
Hemoperfusion Efferon СT for the Extremely Severe Form of COVID-19
Efferon JSCRussian Federation
NCT06374420
Completed
Small Airway Disease And Bronchial Hyperreactivity In Patients With Post Acute Covid-19 Syndrome
Mansoura UniversityEgypt
NCT06362499
Recruiting
Effects of Unsupervised Inspiratory Muscle Training on Ventilation Variability in Post-covid-19 Patients.
Universidade Federal do Rio Gr...Brazil
NCT06360783
Recruitment ...
COVID-19 Quick Start - Test and Treat in Africa
Duke UniversityUnited States of America
NCT06348186
Recruiting
Fascial Tissue Response To Manual Therapy: Implications In Long Covid Rehabilitation
University of the State of San...Brazil
NCT06346210
Completed
Optimal Timing for Tracheostomy in Invasively Mechanically Ventilated COVID-19 Patients
Uppsala UniversitySweden
NCT06309186
Recruiting
Empowerment and Burnout of Midwives at the End of Health Emergency From COVID-19
IRCCS Burlo GarofoloItaly
NCT06300853
Recruiting
Understanding Adaptive Immune Response After COVID-19 Vaccination Boosters to Improve Vaccination Strategies in Vulnerable Groups.
IRCCS Sacro Cuore Don Calabria...Italy
NCT06291857
Phase 2/3
Not yet recr...
A Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine and Influenza Combination Vaccine
Novavax
About COVID-19 Research
Pure Global AI provides free access to 1,961 clinical trials studying COVID-19, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include National Institute of Allergy and Infectious Diseases (NIAID), Assistance Publique - Hôpitaux de Paris, Sinovac Research and Development Co., Ltd., among others.
Quick Facts
Total Trials1,961
Countries10+
Sponsors10+
Recruiting587